Furthermore, we found enhanced expression of EMP1 in BoM-derived fibroblasts in breast cancer (Figure 3B), and these cells were enriched in multiple cancer-related pathways (Figure 4B), confirming the importance of these cells during the BoM process. This evidence concerns the gene GRHL2 and breast cancer.